- Home
- PCVX vs SEIC Comparison
PCVX vs SEIC Comparison
Compare PCVX & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCVX | SEIC |
|---|---|---|
| Founded | 2013 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 9.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | SEIC |
|---|---|---|
| Price | $46.54 | $82.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $101.67 | ★ $102.14 |
| AVG Volume (30 Days) | ★ 1.3M | 611.0K |
| Earning Date | 11-04-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | N/A | ★ 30.71 |
| EPS | N/A | ★ 5.43 |
| Revenue | N/A | ★ $2,246,646,000.00 |
| Revenue This Year | N/A | $9.87 |
| Revenue Next Year | N/A | $8.01 |
| P/E Ratio | ★ N/A | $15.12 |
| Revenue Growth | N/A | ★ 9.44 |
| 52 Week Low | $27.66 | $64.66 |
| 52 Week High | $93.77 | $93.96 |
Technical Indicators
Market Signals| Indicator | PCVX | SEIC |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 49.82 |
| Support Level | $45.21 | $82.65 |
| Resistance Level | $48.65 | $86.98 |
| Average True Range (ATR) | 1.50 | 1.38 |
| MACD | 0.04 | -0.14 |
| Stochastic Oscillator | 67.85 | 25.40 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $87 billion in assets under management. As of December 2024, SEI (including LSV) manages, administers, or advises about $1.6 trillion in assets.